Harpoon Therapeutics to effect 1-for-10 reverse stock split to regain Nasdaq compliance

Harpoon Therapeutics, Inc.

Reverse stock split ratio 1-for-10, effective at 5:00 p.m. ET on September 1, 2023.
Outstanding shares reduced from ~40.3 million to ~4.0 million shares.
Common stock will trade on Nasdaq on a split-adjusted basis from September 5, 2023, under ticker HARP.
No fractional shares issued; stockholders will receive cash for fractional interests.
CUSIP changed to 41358P205; par value remains $0.0001 per share.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Harpoon Therapeutics, Inc.: Filing of Certificate of Amendment to effect a 1-for-10 reverse stock split of common stock, approved by stockholders and the Board, to regain Nasdaq compliance (effective 2023-09-01).

Change: charter amendment
Effective: 2023-09-01

Exact text from the filing

On September 1, 2023, the Company filed with the Secretary of State of the State of Delaware a Certificate of Amendment to its amended and restated certificate of incorporation (the “ Charter Amendment ”) to effect the Reverse Stock Split.

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001193125-23-227267

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.